Search

Your search keyword '"Jongen, J L"' showing total 5 results
Start Over Author "Jongen, J L" Publication Year Range Last 10 years
5 results on '"Jongen, J L"'

1. SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT

Author

Grun, N., Den Otter, C. A., Sintemaartensdijk, M., Osinga, J., Den Elzen, F. E. L., Vegt, A. N., Haan, J., Bruynzeel, A. M. E., Linde, M. E., Postma, T. J., Schuur, M., Hamer, P. C. Witt, Vos, F. Y. F. L., Verhoeff, J. J. C., Jongen, J. L. M., Lissenberg-Witte, B. I., Mathilde Kouwenhoven, Obstetrics and gynaecology, Radiation Oncology, CCA - Cancer Treatment and quality of life, Internal medicine, Neurology, Neurosurgery, Amsterdam Neuroscience - Systems & Network Neuroscience, Molecular cell biology and Immunology, Epidemiology and Data Science, and APH - Methodology

Published
2021

2. P14.13 Severe hematological toxicity during chemoradiation for glioblastoma: Identification of clinical and pharmacological risk factors and consequences for the individual patient

Author

Grun, N, primary, den Otter, C A, additional, Sintemaartensdijk, M, additional, Osinga, J, additional, van den Elzen, F E L, additional, van der Vegt, A N, additional, de Haan, J, additional, Bruynzeel, A M E, additional, van Linde, M E, additional, Postma, T J, additional, Schuur, M, additional, de Witt Hamer, P C, additional, De Vos, F Y F L, additional, Verhoeff, J J C, additional, Jongen, J L M, additional, Lissenberg-witte, B I, additional, and Kouwenhoven, M C M, additional

Published
2021
Full Text
View/download PDF

4. Epstein-Barr virus infection or malignant lymphoma : what you see is not what you get

Author

De Haes, I., Versluis, J., Lam, K. H., Jongen, J. L. M., Doorduijn, J. K., and Kuipers, S.

Subjects
hemic and lymphatic diseases, Human medicine
Abstract

Infectious mononucleosis may mimic lymphoma, both clinically and histopathologically. We present a patient with neurological symptoms and lymphadenopathy, initially diagnosed as Epstein-Barr virus (EBV)-positive angioimmunoblastic T-cell lymphoma (AITL) with cerebrospinal fluid (C SF) localisation based on lymph node pathology and a 30-fold higher EBV load in the CSF compared with serum. However, the patient fully recovered spontaneously and EBV became negative in both CSF and serum, suggestive of a dramatic presentation of EBV meningoencephalitis.

Published
2019

5. To be in pain (or not): a computer enables outpatients to inform their physician.

Author

Oldenmenger, W. H., Witkamp, F. E., Bromberg, J. E. C., Jongen, J. L. M., Lieverse, P. J., Huygen, F. J. P. M., Baan, M. A. G., van Zuylen, L., and van der Rijt, C. C. D.

Subjects
*CANCER pain treatment, *OUTPATIENT medical care, *PATIENT education, *PALLIATIVE treatment, *ELECTRONIC health records
Abstract

Background: In the outpatient oncology clinic, pain management is often inadequate. Incorporating a systematic pain management program into visits is likely to improve this. We implemented an integrated program, including a structured pain assessment, pain treatment protocol and patient education module. In the present study, we investigated whether this intervention improved pain control. Patients and methods: At seven oncology outpatient clinics, patients were asked to register their pain intensity on a touch screen computer. These scores were made available into their electronic medical records. Additionally, a hospitalwide treatment protocol for cancer-related pain and a patient education module were developed. A data warehouse system enabled us to extract patient data from the electronic medical record anonymously and to use them for analysis. The primary outcome of the study was the percentage of patients with moderate to severe pain [current pain (CPI), NRS > 4] measured during 2 weeks at the start and 6 months after implementation. As secondary outcomes, we studied the percentage of pain registrations in specific patient groups and the percentage of patients treated with a curative and a palliative intention with (moderate-severe) pain. Differences were tested with the χ² test. Results: During the first 6 months, 3407 of the 4345 patients (78%) registered their pain intensity on the touch screen computer. The percentage of patients with moderate to severe CPI decreased 32% (P = 0.021): from 12.5% at start to 8.5% after 6 months. More patients in the palliative phase than in the curative phase of their disease registered their pain intensity (82% versus 75%, respectively, P < 0.005), and more patients in the palliative phase experienced moderate to severe pain (23% versus 14%, respectively, P < 0.001). Conclusion: Pain registration by patients themselves is feasible, provides insight into patients' pain intensity and may improve pain control in outpatients with cancer-related pain. Clinical trial number: Because this is an innovation project and not a primary research project, it has no clinical trial number. The protocol and all materials involved were approved by the Institutional Review Board of the Erasmus MC (MEC-2009-324). [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results